wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Cancer II

Total questions: 47

Worksheet time: 27mins

Name
Class
Date
1.

subpopulation of malignant cells which:

detach from parent neoplasm

spread to distant site

formed by secondary mass & spread

a)

Metastasis

b)

primary neoplasm

c)

secondary neoplasm

2.

may be discovered first

histologically resemble primary neoplasm

a)

Metastasis

b)

primary neoplasm

c)

secondary neoplasm

3.

______ survive even when primary tumor has been eradicated

a)

metastases

b)

tumor

c)

cancer

4.

Pathway of Metastatic Spread

"seeding"

spread throughout body fluids

typically within peritoneal area

concerning when surgically removing

a)

Body Cavity

b)

Lymphatic Channels

c)

Blood

5.

Pathway of Metastatic Spread

most common route

for distant metastases

little mechanical resistance to penetrate

a)

Body Cavity

b)

Lymphatic Channels

c)

Blood

6.

Pathway of Metastatic Spread

detach from node & enter efferent vessels

may growth into noticeable lump

a)

Body Cavity

b)

Lymphatic Channels

c)

Blood

7.

Pathway of Metastatic Spread

rate of spread & growth of tumor is correlated with vascularity

a)

Body Cavity

b)

Lymphatic Channels

c)

Blood

8.

Malignant cells are capable of

a)

continuous shed & migration through blood stream

b)
limited growth and differentiation
c)
localized growth and repair
d)

finding their way to blood stream without producing metastasis

9.

to successfully form secondary neoplasm, cancer cells must:

a)

avoid immune cells

b)
remain dormant in the bone marrow and avoid detection
c)
multiply in the bloodstream and invade tissues
d)
lodge itself into capillary network and survive blood stream
10.

SATA

in metastatic distribution, majority of cancer cells are not able to metastasize because:

a)
Most cancer cells thrive in the bloodstream without barriers.
b)

some takes place in capillary network downstream

c)

influence of environment surrounding secondary organ

d)

organ tropism

e)

not enough blood supply

11.

stimulates inappropriate growth / activity

only needs ONE mutation

a)

Proto-oncogenes

b)

Tumor Suppressor gene

c)

Dominant Mutation

d)

Recessive mutation

12.

prevents the arrest of the cell cycle

produce proteins that inhibit growth, enhance differentiation, promote DNA repair & apoptosis

BOTH Copies must be mutated

a)

Proto-oncogenes

b)

Tumor Suppressor gene

c)

Dominant Mutation

d)

Recessive mutation

13.

tumor formed by proto-oncogenes mutation

(a)  

14.

conveys growth factor signal to nucleus

single amino acid change

once activated, RAS always covey message to nucleus to divide

a)

RAS protein

b)

TP53

c)

p53

d)

BRCA1/2

15.

found in about 30% of human cancer

a)

RAS protein

b)

TP53

c)

p53

d)

BRCA1/2

16.

found in about more than 50% of human cancer

a)

RAS protein

b)

TP53

c)

p53

d)

BRCA1/2

17.

produce suppressor gene responsible in activating

DNA repair, growth inhibition, apoptosis

a)

RAS protein

b)

TP53

c)

p53

d)

BRCA1/2

18.

suppressor gene known to be mutated in breast cancer

a)

RAS protein

b)

TP53

c)

p53

d)

BRCA1/2

19.

most human cancer can ONLY arise because of prior exposure to carcinogens

a)

True

b)

False

20.

which cells are inherited when mutated

a)

somatic

b)

germinal

21.

Cancer Screening can be performed through:

a)

Observation,

palpation

b)

imaging

c)

skin tests,

saliva tests

d)

blood test

e)

cytologic and histologic test

22.

In Cancer screening, which is an example of Tumour markers?

a)

detection of new and level change of protein

b)

effusion

c)

increased lymph nodes

23.

microscopic analysis of body secretion/ scrapings

a)

Pap Test

b)

Tissue Biopsy

c)

Immunohistochemistry

24.

removal of tissue specimen for microscopic study

a)

Pap Test

b)

Tissue Biopsy

c)

Immunohistochemistry

25.

use antibiotics to identify cell products or surface markers

a)

Pap Test

b)

Tissue Biopsy

c)

Immunohistochemistry

26.

In Gompertzian Growth Curve, growth plateau in 2 years is shown. What are the possible reasons for it:

a)

low nutrients, angiogenesis, space

b)

increased wastes

c)

metastasis threshold is reached

d)

treatment is working

27.

what are the roles of surgery in caner management?

a)

Cosmetic improvements in patients.

b)

Diagnosing infections unrelated to cancer.

c)

Diagnosis, prognosis, prevention, treatment, & management

d)

Primarily used for chemotherapy administration.

e)

Enhancing radiation therapy effectiveness.

28.

what's the difference between INCISIONAL and EXCISIONAL biopsy?

a)
Incisional biopsy removes part of a lesion; excisional biopsy removes the entire lesion.
b)
Incisional biopsy removes the entire lesion; excisional biopsy removes part of a lesion.
c)
Incisional biopsy is less invasive than excisional biopsy.
d)
Excisional biopsy is performed only on benign lesions; incisional is for malignant.
29.

Aside from removing large tumours, Surgery can be an option to:

a)

prevent local recurrence

b)

de-bulk

c)

palliation

d)

emergency and rehabilitation

e)

lengthen treatment plan

30.

useful for 50-60% of all cancer patients

benefits & side effects limited to areas being treated

a)

chemotherapy

b)

radiotherapy

c)

Palliative Radiotherapy

d)

Hormone Therapy

e)

Immunotherapy

31.

30+ doses use to minimize damage to healthy cells & chance of cell diciding

typically used:

in vital, inaccessible areas

with combination with surgery

a)

chemotherapy

b)

radiotherapy

c)

Palliative Radiotherapy

d)

Hormone Therapy

e)

Immunotherapy

32.

used to treat forms of cancer that are:

-widespread

-rapidly growing

-high risk of micro-metastatic deposits

combined with drugs used for diff mechanisms

a)

chemotherapy

b)

radiotherapy

c)

Palliative Radiotherapy

d)

Hormone Therapy

e)

Immunotherapy

33.

used for painful bone and soft tissue metastases

brain metastases

malignant spinal cord compression

airway obstruction, ulcerating, bleeding lesions

a)

chemotherapy

b)

radiotherapy

c)

Palliative Radiotherapy

d)

Hormone Therapy

e)

Immunotherapy

34.

goal is to slow cancer growth by altering hormonal environment through hormone suppression/receptor changes

a)

chemotherapy

b)

radiotherapy

c)

Palliative Radiotherapy

d)

Hormone Therapy

e)

Immunotherapy

35.

one of the issue for this treatment is, cancer become resistant later

a)

chemotherapy

b)

radiotherapy

c)

Palliative Radiotherapy

d)

Hormone Therapy

e)

Immunotherapy

36.

attempt to increase body's own immune response to cancer

a)

chemotherapy

b)

radiotherapy

c)

Palliative Radiotherapy

d)

Hormone Therapy

e)

Immunotherapy

37.

non-specific treatment with attenuated bacterial strains to stimulate immune system

a)

Active Immunotherapy

b)

Passive Immunotherapy

38.

transfer sensitized NK Cells, T CELLS, Cytokines,

transfer antibodies into patient

a)

Active Immunotherapy

b)

Passive Immunotherapy

39.

form of treatment that works against melanoma

create an environment that is hostile to tumor evolution

(a)  

40.

interferons are

a)

anti-proliferative

b)

pro-apoptotic

c)

immunostimulant

d)

anti-angiogenic

e)

anapilactic suppressor

41.

chemo rounds and cycles kills the same ___ each time.

a)

same percentage but not number of cells

b)

same numbers of cells but not percentage of cells

c)

equivalent number of cells and percentage

42.

target vital cellular machinery

metabolic pathways required for cells

a)

cytotoxic drugs

b)

chemotherapeutic agents

c)

therapeutic index

43.

interferes with synthesis/ function of DNA

more toxic to proliferating cells

a)

cytotoxic drugs

b)

chemotherapeutic agents

c)

therapeutic index

44.

amount of drug required to kill cancer cells

effective dose vs. toxic dose

a)

cytotoxic drugs

b)

chemotherapeutic agents

c)

therapeutic index

45.

chemo has a ____ therapeutic index

a)

LOW

b)

HIGH

46.

most therapies target rapidly dividing cells except

a)
Radiation therapy
b)
Chemotherapy
c)
Immunotherapy
d)
Hormonal therapies
47.

what are examples of most targeted common dividing cells during therapy?

a)

Bone marrow, GI Tract, Hair Skin, Reproductive System

b)

Liver cells, Skin cells, Nerve cells

c)

GI Tract, Nail Skin, Endocrine System, Bone marrow,